期刊文献+

尼可地尔对稳定性心绞痛患者的疗效评价 被引量:22

Efficacy of nicorandil on stable angina
暂未订购
导出
摘要 目的评价尼可地尔对稳定性心绞痛患者的疗效。方法分析2011年4-10月于我院心内科就诊的132例稳定性心绞痛患者,对照组68例,给予除尼可地尔以外的其他稳定性心绞痛常规药物治疗;药物观察组64例,在上述药物基础上加用尼可地尔5 mg,日3次口服,比较两组患者用药前至用药1个月后的疗效。结果治疗1个月后,对照组总有效率51.5%,药物观察组总有效率76.6%,较对照组明显提高(P<0.05);对照组与药物观察组不良反应发生率分别为5.9%与9.4%,两组之间差异无统计学意义(P=0.52)。结论尼可地尔能够有效改善稳定性心绞痛患者的心绞痛症状,是稳定性心绞痛患者的有效治疗药物之一。 Objective To investigate the efficacy of nicorandil on stable angina.Methods 132 patients,hospitalized in our hospital from April 2011 to October 2011,were divided into two groups.68 patients in control group received regular drugs according to guideline,and 64 patients in treatment group took 5 miligrams nicorandil daily except regular drugs.Symptoms and electrocardiogram changes were investigated before and one month after treatment.Results After one month treatment,the effective rates in treatment group(76.6%) is significantly higher than that in control group(51.5%).There were no significant differences in side effect of the two groups(P=0.52).Conclusion Nicorandil is an effective drug to treat stable angina.
出处 《实用药物与临床》 CAS 2012年第3期149-150,共2页 Practical Pharmacy and Clinical Remedies
关键词 尼可地尔 稳定性心绞痛 Nicorandil Stable angina
  • 相关文献

参考文献7

  • 1Taira N.Nicorandil as a hybrid between nitrates and potassiumchannel activators[J].Am J Cardiol,1989,63(21):18-24.
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2193
  • 3Markham A,Plosker GL,Goa KL.Nicorandil.An updated re-view of its use in ischaemic heart disease with emphasis on itscardioprotective effects[J].Drugs,2000,60(4):955-974.
  • 4The IONA study group.Effect of nicorandil on coronary eventsin patients with stable angina:the impact of nicrodil in angina(IONA)randomized trial[J].Lancet,2002,359(9314):1269-1275.
  • 5The Japanese coronary artery disease(JCAD)study investiga-tors.Current status of the background of patients with coronaryartery disease in Japan:The Japanese coronary artery diseasestudy(The JCAD Study)[J].Circ J,2006,70(10):1256-1262.
  • 6Fox K,Garcia MA,Ardissino D,et al.Guidelines on the man-agement of stable angina pectoris:executive summary:The taskforce on the management of stable angina pectoris of the euro-pean society of cardiology[J].Eur Heart J,2006,27(11):1341-1381.
  • 7Healy CM,Smyth Y,Flint SR.Persistent nicorandil induced o-ral ulceration[J].Heart,2004,90(7):e38.

二级参考文献48

  • 1Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 2Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 3Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 4Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 5O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 6Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 7Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 8Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 9Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.
  • 10Kleber AG. ST-segment elevation in the electrocardiogram: a sign of myecaniial iechemia. Cardiovasc Res, 2000,45(1) :111-118.

共引文献2192

同被引文献149

引证文献22

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部